Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Lai, A.Y. Riddell, A. Barwick, T. Boyd, K. Rockall, A. Kaiser, M. Koh, D.-. Saffar, H. Yusuf, S. Messiou, C. (2020). Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. European radiology, Vol.30 (1), pp. 320-327.

Drabbe, C. Benson, C. Younger, E. Zaidi, S. Jones, R.L. Judson, I. Chisholm, J. Mandeville, H. Fisher, C. Thway, K. Al Muderis, O. Messiou, C. Strauss, D. Husson, O. Miah, A. Van der Graaf, W.T. (2020). Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre. Clinical oncology, Vol.32 (1), pp. e27-e35.

Mcaddy, N.C. Hallin, M. Strauss, D. Smith, M. Hayes, A. Yusuf, S. Moskovic, E. Fotiadis, N. van Houdt, W. Jones, R.L. Gronchi, A. Thway, K. Messiou, C. (2020). CT imaging improves histopathological grading of retroperitoneal leiomyosarcomas. European journal of surgical oncology, Vol.46 (2), pp. 288-292.

Alman, B. Attia, S. Baumgarten, C. Benson, C. Blay, J.-. Bonvalot, S. Breuing, J. Cardona, K. Casali, P.G. van Coevorden, F. Colombo, C. Dei Tos, A.P. Dileo, P. Ferrari, A. Fiore, M. Frezza, A.M. Garcia, J. Gladdy, R. Gounder, M. Gronchi, A. Haas, R. Hackett, S. Haller, F. Hohenberger, P. Husson, O. Jones, R.L. Judson, I. Kasper, B. Kawai, A. Kogosov, V. Lazar, A.J. Maki, R. Mathes, T. Messiou, C. Navid, F. Nishida, Y. Palassini, E. Penel, N. Pollock, R. Pieper, D. Portnoy, M. Raut, C.P. Roets, E. Sandrucci, S. Sbaraglia, M. Stacchiotti, S. Thornton, K.A. van der Graaf, W. van der Zande, K. van Houdt, W.J. Villalobos, V. Wagner, A.J. Wardelmann, E. Wartenberg, M. Watson, S. Weiss, A. Zafiropoulos, N. (2020). The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. European journal of cancer, Vol.127, pp. 96-107.

Mayerhoefer, M.E. Archibald, S.J. Messiou, C. Staudenherz, A. Berzaczy, D. Schöder, H. (2020). MRI and PET/MRI in hematologic malignancies. Journal of magnetic resonance imaging, Vol.51 (5), pp. 1325-1335.

Arthurs, O.J. Goh, V. Hoggard, N. Booth, T. Messiou, C. The, J. Plumb, A. Bidaut, L. Turmezei, T. Jethwa, K. Robinson, P. Hall-Craggs, M. (2020). Professional development and research are being neglected: a commentary on the 2019 RCR radiologists' supporting professional activities (SPA) survey. Clinical radiology, Vol.75 (5), pp. 348-350.

Winder, A. Strauss, D.C. Jones, R.L. Benson, C. Messiou, C. Chaudry, M.A. Smith, M.J. (2020). Robotic surgery for gastric gastrointestinal stromal tumors: A single center case series. Journal of surgical oncology, Vol.122 (4), pp. 691-698.

Croft, J. Riddell, A. Koh, D.-. Downey, K. Blackledge, M. Usher, M. Boyd, K. Kaiser, M. Messiou, C. (2020). Inter-observer agreement of baseline whole body MRI in multiple myeloma. Cancer imaging, Vol.20 (1).

CHAMBERLAIN, F. ENGELMANN, B. AL-MUDERIS, O. MESSIOU, C. THWAY, K. MIAH, A. ZAIDI, S. CONSTANTINIDOU, A. BENSON, C. GENNATAS, S. JONES, R.L. (2020). Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy. In vivo, Vol.34 (1), pp. 239-245.

SEBIO, A.N. CONSTANTINIDOU, A. BENSON, C. ANTONIOU, G. MESSIOU, C. MIAH, A. ZAIDI, S. PETRUCKEVITCH, A.N. AL-MUDERIS, O. THWAY, K. VAN DER GRAAF, W.T. JONES, R.L. (2019). Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients. Anticancer research, Vol.39 (1), pp. 347-351.

Barwick, T. Bretsztajn, L. Wallitt, K. Amiras, D. Rockall, A. Messiou, C. (2019). Imaging in myeloma with focus on advanced imaging techniques. The british journal of radiology, Vol.92 (1096), pp. 20180768-20180768.

Messiou, C. Hillengass, J. Delorme, S. Lecouvet, F.E. Moulopoulos, L.A. Collins, D.J. Blackledge, M.D. Abildgaard, N. Østergaard, B. Schlemmer, H.-. Landgren, O. Asmussen, J.T. Kaiser, M.F. Padhani, A. (2019). Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology, Vol.291 (1), pp. 5-13.  show abstract

Ahmed, N. Sriskandarajah, P. Burd, C. Riddell, A. Boyd, K. Kaiser, M. Messiou, C. (2019). Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma. The british journal of radiology, Vol.92 (1097), pp. 20180822-20180822.

TONG, D. CONSTANTINIDOU, A. ENGELMANN, B. CHAMBERLAIN, F. THWAY, K. FISHER, C. HAYES, A. FOTIADIS, N. MESSIOU, C. MIAH, A.B. ZAIDI, S.H. BENSON, C. VAN DER GRAAF, W. JONES, R.L. (2019). The Role of Local Therapy in Multi-focal Epithelioid Haemangioendothelioma. Anticancer research, Vol.39 (9), pp. 4891-4896.

JALY, A.A. THWAY, K. TOUSKA, P. WALE, A. MIAH, A. KERAWALA, C. RIVA, F. MOSKOVIC, E. JONES, R.L. STRAUSS, D. DAFYDD, D.A. MESSIOU, C. (2019). Imaging Soft-tissue Sarcomas of the Head and Neck: A Tertiary Soft-tissue Sarcoma Unit Experience. Anticancer research, Vol.39 (11), pp. 6223-6230.

van Houdt, W.J. Husson, O. Patel, A. Jones, R.L. Smith, M.J. Miah, A.B. Messiou, C. Moskovic, E. Al-Muderis, O. Benson, C. Zaidi, S. Dunlop, A. Strauss, D.C. Hayes, A.J. van der Graaf, W.T. (2019). Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance. Annals of surgical oncology, Vol.26 (13), pp. 4699-4706.

Winfield, J.M. Miah, A.B. Strauss, D. Thway, K. Collins, D.J. deSouza, N.M. Leach, M.O. Morgan, V.A. Giles, S.L. Moskovic, E. Hayes, A. Smith, M. Zaidi, S.H. Henderson, D. Messiou, C. (2019). Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With Histopathology. Frontiers in oncology, Vol.9.

Messiou, C. Morosi, C. (2018). Imaging in retroperitoneal soft tissue sarcoma. Journal of surgical oncology, Vol.117 (1), pp. 25-32.

(2018). Clear Cell Sarcoma-like Tumor of the Gastrointestinal Tract: Clinical Outcome and Pathologic Features of a Molecularly Characterized Tertiary Center Case Series. Anticancer research, Vol.38 (3).

Winfield, J.M. Poillucci, G. Blackledge, M.D. Collins, D.J. Shah, V. Tunariu, N. Kaiser, M.F. Messiou, C. (2018). Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI. European radiology, Vol.28 (4), pp. 1687-1691.

Schrage, Y. Hartgrink, H. Smith, M. Fiore, M. Rutkowski, P. Tzanis, D. Messiou, C. Servois, V. Bonvalot, S. van der Hage, J. (2018). Surgical management of metastatic gastrointestinal stromal tumour. European journal of surgical oncology, Vol.44 (9), pp. 1295-1300.

OWEN, C. CONSTANTINIDOU, A. MIAH, A.B. THWAY, K. FISHER, C. BENSON, C. ZAIDI, S. MESSIOU, C. VAN DER GRAAF, W.T. JONES, R.L. (2018). Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management. Anticancer research, Vol.38 (9), pp. 5275-5282.

Haas, R.L. Gronchi, A. van de Sande, M.A. Baldini, E.H. Gelderblom, H. Messiou, C. Wardelmann, E. Le Cesne, A. (2018). Perioperative Management of Extremity Soft Tissue Sarcomas. Journal of clinical oncology, Vol.36 (2), pp. 118-124.  show abstract

Pender, A. Davis, E.J. Chauhan, D. Messiou, C. Al-Muderis, O. Thway, K. Fisher, C. Zaidi, S. Miah, A. Judson, I. van der Graaf, W. Keedy, V.L. Benson, C. Jones, R.L. (2018). Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma. Medical oncology, Vol.35 (10).

Chew, W. Benson, C. Thway, K. Hayes, A. Miah, A. Zaidi, S. Lee, A.T. Messiou, C. Fisher, C. van der Graaf, W.T. Jones, R.L. (2018). Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma. Medical oncology, Vol.35 (11).

Donners, R. Blackledge, M. Tunariu, N. Messiou, C. Merkle, E.M. Koh, D.-. (2018). Quantitative Whole-Body Diffusion-Weighted MR Imaging. Magnetic resonance imaging clinics of north america, Vol.26 (4), pp. 479-494.

Messiou, C. Kaiser, M. (2018). Whole-Body Imaging in Multiple Myeloma. Magnetic resonance imaging clinics of north america, Vol.26 (4), pp. 509-525.

Libertini, M. Mitra, I. van der Graaf, W.T. Miah, A.B. Judson, I. Jones, R.L. Thomas, K. Moskovic, E. Szucs, Z. Benson, C. Messiou, C. (2018). Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response. Clinical sarcoma research, Vol.8 (1).

Lindner, L.H. Litière, S. Sleijfer, S. Benson, C. Italiano, A. Kasper, B. Messiou, C. Gelderblom, H. Wardelmann, E. Le Cesne, A. Blay, J.-. Marreaud, S. Hindi, N. Desar, I.M. Gronchi, A. van der Graaf, W.T. (2018). Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma. International journal of cancer, Vol.142 (12), pp. 2610-2620.

Spain, L. Walls, G. Messiou, C. Turajlic, S. Gore, M. Larkin, J. (2017). Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series. Cancer immunology, immunotherapy, Vol.66 (1), pp. 113-117.

ap Dafydd, D. Messiou, C. Thway, K. Strauss, D.C. Nicol, D.L. Moskovic, E. (2017). Paratesticular Sarcoma: Typical Presentation, Imaging Features, and Clinical Challenges. Urology, Vol.100, pp. 163-168.

Nanni, C. Cottereau, A.S. Lopci, E. Bodet-Milin, C. Coronado, M. Pro, B. Kim, W.S. Trotman, J. Barrington, S. Duhrsen, U. Vander Borght, T. Zamagni, E. Kraeber-Bodéré, F. Messiou, C. Rahmouni, A. Buvat, I. Andre, M. Hertzberg, M. Oyen, W. Casasnovas, O. Luminari, S. Garderet, L. Montravers, F. Kobe, C. Kluge, R. Versari, A. Zucca, E. Moreau, P. Cheson, B. Haioun, C. Gallamini, A. Meignan, M. (2017). Report of the 6th International Workshop on PET in lymphoma. Leukemia & lymphoma, Vol.58 (10), pp. 2298-2303.

Young, R.J. Litière, S. Lia, M. Hogendoorn, P.C. Fisher, C. Mechtersheimer, G. Daugaard, S. Sciot, R. Collin, F. Messiou, C. Grünwald, V. Gronchi, A. van der Graaf, W. Wardelmann, E. Judson, I. (2017). Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study. Acta oncologica, Vol.56 (7), pp. 1013-1020.

Szucs, Z. Messiou, C. Wong, H.H. Hatcher, H. Miah, A. Zaidi, S. van der Graaf, W.T. Judson, I. Jones, R.L. Benson, C. (2017). Pazopanib, a promising option for the treatment of aggressive fibromatosis. Anti-cancer drugs, Vol.28 (4), pp. 421-426.

Winfield, J.M. Tunariu, N. Rata, M. Miyazaki, K. Jerome, N.P. Germuska, M. Blackledge, M.D. Collins, D.J. de Bono, J.S. Yap, T.A. deSouza, N.M. Doran, S.J. Koh, D.-. Leach, M.O. Messiou, C. Orton, M.R. (2017). Extracranial Soft-Tissue Tumors: Repeatability of Apparent Diffusion Coefficient Estimates from Diffusion-weighted MR Imaging. Radiology, Vol.284 (1), pp. 88-99.  show abstract

Messiou, C. Moskovic, E. Vanel, D. Morosi, C. Benchimol, R. Strauss, D. Miah, A. Douis, H. van Houdt, W. Bonvalot, S. (2017). Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm. European journal of surgical oncology (ejso), Vol.43 (7), pp. 1191-1198.

van Houdt, W.J. Zaidi, S. Messiou, C. Thway, K. Strauss, D.C. Jones, R.L. (2017). Treatment of retroperitoneal sarcoma. Current opinion in oncology, Vol.29 (4), pp. 260-267.

Smith, H.G. Tzanis, D. Messiou, C. Benson, C. van der Hage, J.A. Fiore, M. Bonvalot, S. Hayes, A.J. (2017). The management of soft tissue tumours of the abdominal wall. European journal of surgical oncology, Vol.43 (9), pp. 1647-1655.

van Houdt, W.J. Patel, A.K. Jones, R.L. Smith, M.J. Miah, A. Benson, C. Zaidi, S. Messiou, C. Moskovic, E. Strauss, D.C. Hayes, A.J. Husson, O. van der Graaf, W.T. (2017). Prognosis of desmoid tumours initially managed with surveillance only at all anatomical locations. Annals of oncology, Vol.28.

Morone, M. Bali, M.A. Tunariu, N. Messiou, C. Blackledge, M. Grazioli, L. Koh, D.-. (2017). Whole-Body MRI: Current Applications in Oncology. American journal of roentgenology, Vol.209 (6), pp. W336-W349.

(2017). Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group. Annals of surgical oncology, Vol.24 (S3), pp. 688-689.

Seifert, H. Hirata, E. Gore, M. Khabra, K. Messiou, C. Larkin, J. Sahai, E. (2016). Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases. Pigment cell & melanoma research, Vol.29 (1), pp. 92-100.

Wardelmann, E. Haas, R.L. Bovée, J.V. Terrier, P. Lazar, A. Messiou, C. LePechoux, C. Hartmann, W. Collin, F. Fisher, C. Mechtersheimer, G. DeiTos, A.P. Stacchiotti, S. Jones, R.L. Gronchi, A. Bonvalot, S. (2016). Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting. European journal of cancer, Vol.53, pp. 84-95.

Smith, H.G. Hannay, J.A. Thway, K. Messiou, C. Smith, M.J. Strauss, D.C. Hayes, A.J. (2016). Elastofibroma dorsi: The clunking tumour that need not cause alarm. The annals of the royal college of surgeons of england, Vol.98 (03), pp. 208-211.  show abstract

Messiou, C. Bonvalot, S. Gronchi, A. Vanel, D. Meyer, M. Robinson, P. Morosi, C. Bloem, J.L. Terrier, P.H. Lazar, A. Le Péchoux, C. Wardelman, E. Winfield, J.M. Boulet, B. Bovée, J. Haas, R.L. (2016). Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC – STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging. European journal of cancer, Vol.56, pp. 37-44.

Wale, A. Pawlyn, C. Kaiser, M. Messiou, C. (2016). Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma. Haematologica, Vol.101 (4), pp. e142-e144.

Orton, M.R. Messiou, C. Collins, D. Morgan, V.A. Tessier, J. Young, H. deSouza, N. Leach, M.O. (2016). Diffusion-weighted MR imaging of metastatic abdominal and pelvic tumours is sensitive to early changes induced by a VEGF inhibitor using alternative diffusion attenuation models. European radiology, Vol.26 (5), pp. 1412-1419.

Vlenterie, M. Litière, S. Rizzo, E. Marréaud, S. Judson, I. Gelderblom, H. Le Cesne, A. Wardelmann, E. Messiou, C. Gronchi, A. van der Graaf, W.T. (2016). Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity. European journal of cancer, Vol.58, pp. 62-72.

Pawlyn, C. Fowkes, L. Otero, S. Jones, J.R. Boyd, K.D. Davies, F.E. Morgan, G.J. Collins, D.J. Sharma, B. Riddell, A. Kaiser, M.F. Messiou, C. (2016). Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?. Leukemia, Vol.30 (6), pp. 1446-1448.

Rata, M. Collins, D.J. Darcy, J. Messiou, C. Tunariu, N. Desouza, N. Young, H. Leach, M.O. Orton, M.R. (2016). Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions. European radiology, Vol.26 (7), pp. 1991-1998.

Grünwald, V. Litière, S. Young, R. Messiou, C. Lia, M. Wardelmann, E. van der Graaf, W. Gronchi, A. Judson, I. (2016). Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma – An analysis of the EORTC 62012 study of the EORTC STBSG. European journal of cancer, Vol.64, pp. 44-51.

Wang, J. Strauss, D.C. Messiou, C. Thway, K. (2016). Endometriosis of Extra-Abdominal Soft Tissues. International journal of surgical pathology, Vol.24 (6), pp. 497-503.

(2016). Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group. Annals of surgical oncology, Vol.23 (11), pp. 3531-3540.

Thway, K. Noujaim, J. Zaidi, S. Miah, A.B. Benson, C. Messiou, C. Jones, R.L. Fisher, C. (2016). Desmoplastic Small Round Cell Tumor. International journal of surgical pathology, Vol.24 (8), pp. 672-684.

Smith, H.G. Thway, K. Messiou, C. Barton, D.P. Thomas, J.M. Hayes, A.J. Strauss, D.C. Smith, M.J. (2016). Selective marginal resections in the management of aggressive angiomyxomas. Journal of surgical oncology, Vol.114 (7), pp. 828-832.

Messiou, C. Vanel, D. Pollock, R. Cooke, M. Moskovic, E. Savidge, C. King, L. Patel, A. Jones, R.L. (2016). CHRISTMAS 2016: FAMOUS FIGURES Dear John Hunter. Bmj-british medical journal, Vol.355, p. 4.

Harris, L.M. Tunariu, N. Messiou, C. Hughes, J. Wallace, T. DeSouza, N.M. Leach, M.O. Payne, G.S. (2015). Evaluation of lactate detection using selective multiple quantum coherence in phantoms and brain tumours. Nmr in biomedicine, Vol.28 (3), pp. 338-343.

Payne, G.S. deSouza, N.M. Messiou, C. Leach, M.O. (2015). Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter. Nmr in biomedicine, Vol.28 (4), pp. 496-504.

Giles, S.L. deSouza, N.M. Collins, D.J. Morgan, V.A. West, S. Davies, F.E. Morgan, G.J. Messiou, C. (2015). Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden. Clinical radiology, Vol.70 (6), pp. 614-621.

Wilkinson, M.J. Fitzgerald, J.E. Strauss, D.C. Hayes, A.J. Thomas, J.M. Messiou, C. Fisher, C. Benson, C. Tekkis, P.P. Judson, I. (2015). Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib. British journal of surgery, Vol.102 (8), pp. 965-971.

Otero, S. Moskovic, E.C. Strauss, D.C. Benson, C. Miah, A.B. Thway, K. Messiou, C. (2015). Desmoid-type fibromatosis. Clinical radiology, Vol.70 (9), pp. 1038-1045.

Noujaim, J. Constantinidou, A. Messiou, C. Thway, K. Miah, A. Benson, C. Judson, I. Jones, R.L. (2015). Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma. American journal of clinical oncology, , pp. 1-1.

Ng, W. Messiou, C. Smith, M. Thway, K. (2015). p16 Expression in Fat Necrosis. International journal of surgical pathology, Vol.23 (7), pp. 544-548.

Messiou, C. Kaiser, M. (2015). Whole body diffusion weighted MRI - a new view of myeloma. British journal of haematology, Vol.171 (1), pp. 29-37.

Maruzzo, M. Martin-Liberal, J. Messiou, C. Miah, A. Thway, K. Alvarado, R. Judson, I. Benson, C. (2015). Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience. Clinical sarcoma research, Vol.5 (1), pp. 5-5.

Messiou, C. Collins, D.J. Morgan, V.A. Bianchini, D. de Bono, J.S. de Souza, N.M. (2014). Use of apparent diffusion coefficient as a response biomarker in bone: effect of developing sclerosis on quantified values. Skeletal radiology, Vol.43 (2), pp. 205-208.

Miah, A.B. Hannay, J. Benson, C. Thway, K. Messiou, C. Hayes, A.J. Strauss, D.C. (2014). Optimal management of primary retroperitoneal sarcoma: an update. Expert review of anticancer therapy, Vol.14 (5), pp. 565-579.

Giles, S.L. Messiou, C. Collins, D.J. Morgan, V.A. Simpkin, C.J. West, S. Davies, F.E. Morgan, G.J. deSouza, N.M. (2014). Whole-Body Diffusion-weighted MR Imaging for Assessment of Treatment Response in Myeloma. Radiology, Vol.271 (3), pp. 785-794.

Bashir, U. Moskovic, E. Strauss, D. Hayes, A. Thway, K. Pope, R. Messiou, C. (2014). Soft-tissue masses in the abdominal wall. Clinical radiology, Vol.69 (10), pp. e422-e431.

Lecouvet, F.E. Talbot, J.N. Messiou, C. Bourguet, P. Liu, Y. de Souza, N.M. (2014). Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. European journal of cancer, Vol.50 (15), pp. 2519-2531.

Kollàr, A. Maruzzo, M. Messiou, C. Cartwright, E. Miah, A. Martin-Liberal, J. Thway, K. McGrath, E. Dunlop, A. Khabra, K. Seddon, B. Dileo, P. Linch, M. Judson, I. Benson, C. (2014). Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program. Clinical sarcoma research, Vol.4 (1).

Martin-Liberal, J. Benson, C. Messiou, C. Fisher, C. Judson, I. (2014). Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal Sarcoma. Case reports in medicine, Vol.2014, pp. 1-5.  show abstract

Sandhu, S.K. Papadopoulos, K. Fong, P.C. Patnaik, A. Messiou, C. Olmos, D. Wang, G. Tromp, B.J. Puchalski, T.A. Balkwill, F. Berns, B. Seetharam, S. de Bono, J.S. Tolcher, A.W. (2013). A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer chemotherapy and pharmacology, Vol.71 (4), pp. 1041-1050.

Martin-Liberal, J. Benson, C. McCarty, H. Thway, K. Messiou, C. Judson, I. (2013). Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis. Clinical sarcoma research, Vol.3 (1).

Martin-Liberal, J. Alam, S. Constantinidou, A. Fisher, C. Khabra, K. Messiou, C. Olmos, D. Mitchell, S. Al-Muderis, O. Miah, A. Linch, M. Jones, R.L. Scurr, M. Judson, I. Benson, C. (2013). Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma. Sarcoma, Vol.2013, pp. 1-6.

Messiou, C. Orton, M. Ang, J.E. Collins, D.J. Morgan, V.A. Mears, D. Castellano, I. Papadatos-Pastos, D. Brunetto, A. Tunariu, N. Mann, H. Tessier, J. Young, H. Ghiorghiu, D. Marley, S. Kaye, S.B. deBono, J.S. Leach, M.O. deSouza, N.M. (2012). Advanced Solid Tumors Treated with Cediranib: Comparison of Dynamic Contrast-enhanced MR Imaging and CT as Markers of Vascular Activity. Radiology, Vol.265 (2), pp. 426-436.

Messiou, C. Giles, S. Collins, D.J. West, S. Davies, F.E. Morgan, G.J. Desouza, N.M. (2012). Assessing response of myeloma bone disease with diffusion-weighted MRI. The british journal of radiology, Vol.85 (1020), pp. e1198-e1203.

Messiou, C. Cook, G. Reid, A.H. Attard, G. Dearnaley, D. de Bono, J.S. de Souza, N.M. (2011). The CT flare response of metastatic bone disease in prostate cancer. Acta radiol, Vol.52 (5), pp. 557-561.  show abstract

Messiou, C. Collins, D.J. Morgan, V.A. Desouza, N.M. (2011). Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur radiol, .  show abstract

Kyriazi, S. Collins, D.J. Messiou, C. Pennert, K. Davidson, R.L. Giles, S.L. Kaye, S.B. deSouza, N.M. (2011). Metastatic Ovarian and Primary Peritoneal Cancer: Assessing Chemotherapy Response with Diffusion-weighted MR Imaging—Value of Histogram Analysis of Apparent Diffusion Coefficients. Radiology, Vol.261 (1), pp. 182-192.

Messiou, C. Collins, D.J. Giles, S. de Bono, J.S. Bianchini, D. de Souza, N.M. (2011). Assessing response in bone metastases in prostate cancer with diffusion weighted MRI. European radiology, Vol.21 (10), pp. 2169-2177.

Messiou, C. Collins, D.J. Morgan, V.A. Robson, M.D. deBono, J.S. Bydder, G.M. deSouza, N.M. (2011). Quantifying sclerotic bone metastases with 2D ultra short TE MRI: A feasibility study. Cancer biomarkers, Vol.7 (4-5), pp. 211-218.

Messiou, C. deSouza, N.M. (2011). Metastasis imaging: Current concepts and future challenges. Cancer biomarkers, Vol.7 (4-5), pp. 171-172.

Messiou, C. deSouza, N.M. (2010). Diffusion Weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring. Cancer biomarkers, Vol.6 (1), pp. 21-32.

Fong, P.C. Yap, T.A. Boss, D.S. Carden, C.P. Mergui-Roelvink, M. Gourley, C. De Greve, J. Lubinski, J. Shanley, S. Messiou, C. A'Hern, R. Tutt, A. Ashworth, A. Stone, J. Carmichael, J. Schellens, J.H. de Bono, J.S. Kaye, S.B. (2010). Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval. Journal of clinical oncology, Vol.28 (15), pp. 2512-2519.  show abstract

Reid, A.H. Attard, G. Danila, D.C. Oommen, N.B. Olmos, D. Fong, P.C. Molife, L.R. Hunt, J. Messiou, C. Parker, C. Dearnaley, D. Swennenhuis, J.F. Terstappen, L.W. Lee, G. Kheoh, T. Molina, A. Ryan, C.J. Small, E. Scher, H.I. de Bono, J.S. (2010). Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate. J clin oncol, Vol.28 (9), pp. 1489-1495.  show abstract

Forster, M.D. Patnaik, A. Sandhu, S.K. Papadopoulos, K. Tromp, B.J. Messiou, C. Balkwill, F. Berns, B. De Bono, J.S. Tolcher, A.W. (2010). Pre-final analysis of first-in-human, first-in-class, phase I clinical trial of CNTO 888, a human monoclonal antibody to the CC-chemokine ligand 2 (CCL2) in patients (pts) with advanced solid tumors. Journal of clinical oncology, Vol.28 (15_suppl), pp. 2548-2548.

Messiou, C. deSouza, N.M. (2009). State-of-the-art imaging for detecting cancer in the clinic. Future oncol, Vol.5 (2), pp. 135-139.

Messiou, C. Morgan, V.A. De Silva, S.S. Ind, T.E. deSouza, N.M. (2009). Diffusion weighted imaging of the uterus: regional ADC variation with oral contraceptive usage and comparison with cervical cancer. Acta radiol, Vol.50 (6), pp. 696-701.  show abstract

Doyle, S. Messiou, C. Rutherford, J.M. Dineen, R.A. (2009). Cancer presenting during pregnancy: radiological perspectives. Clinical radiology, Vol.64 (9), pp. 857-871.

Attard, G. Reid, A.H. A'Hern, R. Parker, C. Oommen, N.B. Folkerd, E. Messiou, C. Molife, L.R. Maier, G. Thompson, E. Olmos, D. Sinha, R. Lee, G. Dowsett, M. Kaye, S.B. Dearnaley, D. Kheoh, T. Molina, A. de Bono, J.S. (2009). Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. J clin oncol, Vol.27 (23), pp. 3742-3748.  show abstract

Sandhu, S.K. Fong, P.C. Patnaik, A. Papadopoulos, K. Messiou, C. Hoare, S. Olmos, D. Tromp, B.J. Puchalski, T.A. Balkwill, F. Berns, B. Debono, J.S. Tolcher, A.W. (2009). Abstract A102: First‐in‐man, first‐in‐class, pharmacokinetic and pharmacodynamic phase I clinical trial of a human monoclonal antibody CNTO888 to CC‐chemokine ligand 2 (CCL2) / monocyte chemoattractant protein (MCP‐1) in patients with advanced solid tumors. Clinical trials, .

Messiou, C. Cook, G. deSouza, N.M. (2009). Imaging metastatic bone disease from carcinoma of the prostate. Br j cancer, Vol.101 (8), pp. 1225-1232.  show abstract

MESSIOU, C. CHALMERS, A.G. BOYLE, K. WILSON, D. SAGAR, P. (2008). Pre-operative MR assessment of recurrent rectal cancer. The british journal of radiology, Vol.81 (966), pp. 468-473.

Charles-Edwards, E.M. Messiou, C. Morgan, V.A. De Silva, S.S. McWhinney, N.A. Katesmark, M. Attygalle, A.D. deSouza, N.M. (2008). Diffusion-weighted Imaging in Cervical Cancer with an Endovaginal Technique: Potential Value for Improving Tumor Detection in Stage Ia and Ib1 Disease. Radiology, Vol.249 (2), pp. 541-550.

Spencer, J.A. (2008). MR staging of endometrial cancer: needed or wanted?. Cancer imaging, Vol.8 (1), pp. 1-5.

Messiou, C. Robinson, P. O’Connor, P.J. Grainger, A. (2006). Subacute posteromedial impingement of the ankle in athletes: MR imaging evaluation and ultrasound guided therapy. Skeletal radiology, Vol.35 (2), pp. 88-94.

Messiou, C. Chalmers, A. Boyle, K. Sagar, P. (2006). Surgery for recurrent rectal carcinoma: The role of preoperative magnetic resonance imaging. Clinical radiology, Vol.61 (3), pp. 250-258.

Messiou, C. Spencer, J.A. Swift, S.E. (2006). MR staging of endometrial carcinoma. Clinical radiology, Vol.61 (10), pp. 822-832.

Messiou, C. Chalmers, A.G. Dexter, S. (2005). An unusual case of ureteric obstruction. The british journal of radiology, Vol.78 (933), pp. 848-850.

Hutcheon, G. (2001). Water absorption and surface properties of novel poly(ethylmethacrylate) polymer systems for use in bone and cartilage repair. Biomaterials, Vol.22 (7), pp. 667-676.

Payne, G.S. Harris, L.M. Cairns, G.S. Desouza, N.M. Saran, F. Leach, M.O. Validating a robust double-quantum-filtered 1H MRS lactate measurement method in high-grade brain tumours. Nmr in biomedicine, .

Stoneham, A. Thway, K. Messiou, C. Smith, M. Cyclist's nodule: no smooth ride. Bmj case reports, , pp. bcr2015213087-bcr2015213087.

Messiou, C. Vanel, D. Pollock, R. Cooke, M. Moskovic, E. Savidge, C. King, L. Patel, A. Jones, R.L. Dear John Hunter. Bmj, , pp. i6515-i6515.

van der Graaf, W. AN UPDATE ON THE MANAGEMENT OF SPORADIC DESMOID-TYPE FIBROMATOSIS: A EUROPEAN CONSENSUS INITIATIVE BETWEEN SARCOMA PATIENTS EURONET (SPAEN) AND EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) / SOFT TISSUE AND BONE SARCOMA GROUP (STBSG). Annals of oncology, .

Cairncross, L. Snow, H.A. Strauss, D.C. Smith, M.J. Sjokvist, O. Messiou, C. Thway, K. Hayes, A.J. Diagnostic performance of MRI and histology in assessment of deep lipomatous tumours. Bjs, .

Blackledge, M.D. Winfield, J.M. Miah, A. Strauss, D. Thway, K. Morgan, V.A. Collins, D.J. Koh, D.-. Leach, M.O. Messiou, C. Supervised Machine-Learning Enables Segmentation and Evaluation of Heterogeneous Post-treatment Changes in Multi-Parametric MRI of Soft-Tissue Sarcoma. Frontiers in oncology, Vol.9.

Snow, H. Hazell, S. Francis, N. Mohammed, K. O'Neill, S. Davies, E. Mansfield, D. Messiou, C. Hujairi, N. Nicol, D. Harrington, K. Smith, M. Prostate‐specific membrane antigen expression in melanoma metastases. Journal of cutaneous pathology, .

Hameed, M. Sandhu, A. Soneji, N. Amiras, D. Rockall, A. Messiou, C. Wallitt, K. Barwick, T.D. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging. The british journal of radiology, , pp. 20200312-20200312.  show abstract

Tunariu, N. Blackledge, M. Messiou, C. Petralia, G. Padhani, A. Curcean, S. Curcean, A. Koh, D.-. What’s New for Clinical Whole-body MRI (WB-MRI) in the 21st Century. The british journal of radiology, , pp. 20200562-20200562.  show abstract


Conferences

Chamberlain, F.Cojocaru, E.Scaranti, M.Noujaim, J.Constantinou, A.Thway, K.Fisher, C.Messiou, C.Strauss, D.C.Miah, A.Zaidi, S.Benson, C.Gennatas, S.Jones, R.L. (2020). Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy, Medical Oncology, Vol.37 (2).

Bishr, M.Nicholson, E.Durie, E.Potter, M.Ethell, M.Anthias, C.Messiou, C.Johnson, I.Eagle, S.Ingram, W.Saran, F.Mandeville, H. (2019). PO-0869 Reducing pulmonary and renal toxicity in children receiving TBI with forward planned IMRT, Radiotherapy and Oncology, Vol.133, p.S458.

Sriskandarajah, P.Ahmed, N.Burd, C.Shah, V.Riddell, A.Boyd, K.Kaiser, M.Messiou, C. (2018). Detection of asymptomatic femoral head avascular necrosis on routine whole body MRI in patients with multiple myeloma provides opportunities for joint preservation, BRITISH JOURNAL OF HAEMATOLOGY, Vol.181, p.98.

Durie, E.Nicholson, E.Anthias, C.Dunne, E.Potter, M.Ethell, M.Messiou, C.Brennan, J.Eagle, S.Ingram, W.Saran, F.Mandeville, H. (2018). OC-0386: Incidence of pneumonitis and CKD following novel FP IMRT TBI conditioning for full intensity HSCT, Radiotherapy and Oncology, Vol.127, pp.S197-S198.

Durie, E.Nicholson, E.Anthias, C.Dunne, E.Potter, M.Ethell, M.Messiou, C.Brennan, J.Eagle, S.Ingram, W.Saran, F.Mandeville, H. (2018). Low incidence of interstitial pneumonitis and chronic kidney disease post myeloablative stem cell transplant using novel forward planned intensity modulated IMRT total body irradiation technique, BONE MARROW TRANSPLANTATION, Vol.53, pp.281-282.

Rieu, R.Benson, C.Dunlop, A.Khabra, K.Al-Muderis, O.Jones, R.Van der Graaf, W.Fisher, C.Thway, K.Messiou, C.Judson, I.Miah, A.Zaidi, S. (2016). PO-0765: Management of primary cardiac and great vessel sarcomas, The RMH experience 2000-2015, Radiotherapy and Oncology, Vol.119, pp.S358-S359.

Pawlyn, C.Kaiser, M.F.Fowkes, L.Jones, J.R.Davies, F.E.Morgan, G.J.Collins, D.Sharma, B.Riddell, A.Messiou, C. (2015). WB-DWI MRI Scanning Outperforms FDG PET-CT for the Assessment of Myeloma Disease Burden, BLOOD, Vol.126 (23).

Wale, A.Pawlyn, C.Kaiser, M.Messiou, C. (2015). WHOLE BODY DIFFUSION WEIGHTED MRI SCANNING IN PATIENTS WITH MYELOMA. INCIDENTAL FINDINGS-THE ROYAL MARSDEN EXPERIENCE, HAEMATOLOGICA, Vol.100, p.88.

Grünwald, V.Litiere, S.Young, R.J.Messiou, C.Michela, L.Wardelmann, E.Van der Graaf, W.Gronchi, A.Judson, I. (2015). 3401 Absence of progression, not extent of remission defines prognosis in soft tissue sarcoma - an analysis of the EORTC 62012 study, European Journal of Cancer, Vol.51, p.S688.

In this section

Publications Research overview Research projects